Follow
Nicholas La Thangue
Nicholas La Thangue
Verified email at oncology.ox.ac.uk
Title
Cited by
Cited by
Year
Selective inhibition of BET bromodomains
P Filippakopoulos, J Qi, S Picaud, Y Shen, WB Smith, O Fedorov, ...
Nature 468 (7327), 1067-1073, 2010
41872010
p300/CBP proteins: HATs for transcriptional bridges and scaffolds
HM Chan, NB La Thangue
Journal of cell science 114 (13), 2363-2373, 2001
14362001
Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein
K Martin, D Trouche, C Hagemeier, TS Sorensen, NB La Thangue, ...
Nature 375 (6533), 691-694, 1995
6231995
Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor
LR Bandara, NB La Thangue
Nature 351 (6326), 494-497, 1991
5901991
Arginine methylation regulates the p53 response
M Jansson, ST Durant, EC Cho, S Sheahan, M Edelmann, B Kessler, ...
Nature cell biology 10 (12), 1431-1439, 2008
5692008
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
O Khan, NB La Thangue
Immunology and cell biology 90 (1), 85-94, 2012
5362012
Chk2 activates E2F-1 in response to DNA damage
C Stevens, L Smith, NB La Thangue
Nature cell biology 5 (5), 401-409, 2003
4812003
Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101
JA Plumb, PW Finn, RJ Williams, MJ Bandara, MR Romero, CJ Watkins, ...
Molecular cancer therapeutics 2 (8), 721-728, 2003
4512003
SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability
SX Pfister, S Ahrabi, LP Zalmas, S Sarkar, F Aymard, CZ Bachrati, ...
Cell reports 7 (6), 2006-2018, 2014
4492014
DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control
NB La Thangue
Trends in biochemical sciences 19 (3), 108-114, 1994
4351994
HDAC inhibitor-based therapies: can we interpret the code?
M New, H Olzscha, NB La Thangue
Molecular oncology 6 (6), 637-656, 2012
4132012
Cyclin A and the retinoblastoma gene product complex with a common transcription factor
LR Bandara, JP Adamczewski, T Hunt, NB La Thangue
Nature 352 (6332), 249-251, 1991
3851991
Functional synergy between DP‐1 and E2F‐1 in the cell cycle‐regulating transcription factor DRTF1/E2F.
LR Bandara, VM Buck, M Zamanian, LH Johnston, NB La Thangue
The EMBO journal 12 (11), 4317-4324, 1993
3641993
A new component of the transcription factor DRTF1/E2F
R Girling, JF Partridge, LR Bandara, N Burden, NF Totty, JJ Hsuan, ...
Nature 362 (6415), 83-87, 1993
3641993
Acetylation control of the retinoblastoma tumour-suppressor protein
HM Chan, M Krstic-Demonacos, L Smith, C Demonacos, NBL Thangue
Nature cell biology 3 (7), 667-674, 2001
3582001
Predictive biomarkers: a paradigm shift towards personalized cancer medicine
NB La Thangue, DJ Kerr
Nature reviews Clinical oncology 8 (10), 587-596, 2011
3492011
A novel cofactor for p300 that regulates the p53 response
N Shikama, CW Lee, S France, L Delavaine, J Lyon, M Krstic-Demonacos, ...
Molecular cell 4 (3), 365-376, 1999
3041999
p53-cofactor JMY is a multifunctional actin nucleation factor
JB Zuchero, AS Coutts, ME Quinlan, NBL Thangue, RD Mullins
Nature cell biology 11 (4), 451-459, 2009
3012009
Inhibiting WEE1 selectively kills histone H3K36me3-deficient cancers by dNTP starvation
SX Pfister, E Markkanen, Y Jiang, S Sarkar, M Woodcock, G Orlando, ...
Cancer cell 28 (5), 557-568, 2015
2912015
E2F and cell cycle control: a double-edged sword
C Stevens, NB La Thangue
Archives of biochemistry and biophysics 412 (2), 157-169, 2003
2762003
The system can't perform the operation now. Try again later.
Articles 1–20